These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 3501720

  • 1. In situ inhibition of tyrosine protein kinase by erbstatin.
    Imoto M, Umezawa K, Sawa T, Takeuchi T, Umezawa H.
    Biochem Int; 1987 Nov; 15(5):989-95. PubMed ID: 3501720
    [Abstract] [Full Text] [Related]

  • 2. Limited selectivity of a synthetic erbstatin derivative for tyrosine kinase and cell growth inhibition.
    Treuner M, Böhmer FD, Schulze W, Petuchov SP, Grosse R.
    Biochem Int; 1992 Mar; 26(4):617-25. PubMed ID: 1319149
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of EGF-induced cytoskeletal change in A431 cells by inhibitors of phosphatidylinositol turnover.
    Johtoh N, Umezawa K.
    Drugs Exp Clin Res; 1992 Mar; 18(1):1-7. PubMed ID: 1600863
    [Abstract] [Full Text] [Related]

  • 4. Comparison of protein phosphorylations in variant A431 cells with different growth responses to epidermal growth factor.
    Buss JE, Chouvet C, Gill GN.
    J Cell Physiol; 1984 Jun; 119(3):296-306. PubMed ID: 6202705
    [Abstract] [Full Text] [Related]

  • 5. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.
    Panek RL, Lu GH, Klutchko SR, Batley BL, Dahring TK, Hamby JM, Hallak H, Doherty AM, Keiser JA.
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of growth factor-mediated tyrosine phosphorylation in vascular smooth muscle by PD 089828, a new synthetic protein tyrosine kinase inhibitor.
    Dahring TK, Lu GH, Hamby JM, Batley BL, Kraker AJ, Panek RL.
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1446-56. PubMed ID: 9190882
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of epidermal growth factor-induced DNA synthesis by tyrosine kinase inhibitors.
    Umezawa K, Hori T, Tajima H, Imoto M, Isshiki K, Takeuchi T.
    FEBS Lett; 1990 Jan 29; 260(2):198-200. PubMed ID: 2298299
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
    Major TC, Keiser JA.
    J Pharmacol Exp Ther; 1997 Oct 29; 283(1):402-10. PubMed ID: 9336349
    [Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity.
    Gulli LF, Palmer KC, Chen YQ, Reddy KB.
    Cell Growth Differ; 1996 Feb 29; 7(2):173-8. PubMed ID: 8822200
    [Abstract] [Full Text] [Related]

  • 10. Modulation of hepatic acute phase gene expression by epidermal growth factor and Src protein tyrosine kinases in murine and human hepatic cells.
    Wang Y, Ripperger J, Fey GH, Samols D, Kordula T, Wetzler M, Van Etten RA, Baumann H.
    Hepatology; 1999 Sep 29; 30(3):682-97. PubMed ID: 10462375
    [Abstract] [Full Text] [Related]

  • 11. Activation of tyrosine kinases by alpha1A-adrenergic and growth factor receptors in transfected PC12 cells.
    Zhong H, Minneman KP.
    Biochem J; 1999 Dec 15; 344 Pt 3(Pt 3):889-94. PubMed ID: 10585878
    [Abstract] [Full Text] [Related]

  • 12. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
    Brunton VG, Carlin S, Workman P.
    Anticancer Drug Des; 1994 Aug 15; 9(4):311-29. PubMed ID: 7916899
    [Abstract] [Full Text] [Related]

  • 13. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
    Showalter HD, Sercel AD, Leja BM, Wolfangel CD, Ambroso LA, Elliott WL, Fry DW, Kraker AJ, Howard CT, Lu GH, Moore CW, Nelson JM, Roberts BJ, Vincent PW, Denny WA, Thompson AM.
    J Med Chem; 1997 Feb 14; 40(4):413-26. PubMed ID: 9046331
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
    Pukac LA, Carter JE, Ottlinger ME, Karnovsky MJ.
    J Cell Physiol; 1997 Jul 14; 172(1):69-78. PubMed ID: 9207927
    [Abstract] [Full Text] [Related]

  • 15. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity.
    Gardner DP, Shimizu N.
    J Cell Physiol; 1994 Feb 14; 158(2):245-55. PubMed ID: 8106561
    [Abstract] [Full Text] [Related]

  • 16. Tyrosine kinase inhibitors. 13. Structure-activity relationships for soluble 7-substituted 4-[(3-bromophenyl)amino]pyrido[4,3-d]pyrimidines designed as inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor.
    Thompson AM, Murray DK, Elliott WL, Fry DW, Nelson JA, Showalter HD, Roberts BJ, Vincent PW, Denny WA.
    J Med Chem; 1997 Nov 21; 40(24):3915-25. PubMed ID: 9397172
    [Abstract] [Full Text] [Related]

  • 17. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
    Shah BH, Olivares-Reyes JA, Catt KJ.
    Mol Pharmacol; 2005 Jan 21; 67(1):184-94. PubMed ID: 15465928
    [Abstract] [Full Text] [Related]

  • 18. Modulation of the protein tyrosine kinase activity and autophosphorylation of the epidermal growth factor receptor by its juxtamembrane region.
    Poppleton HM, Wiepz GJ, Bertics PJ, Patel TB.
    Arch Biochem Biophys; 1999 Mar 15; 363(2):227-36. PubMed ID: 10068444
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of CDP-DG:inositol transferase activity in src- and erbB2-transformed cells.
    Imoto M, Taniguchi Y, Fujiwara H, Umezawa K.
    Exp Cell Res; 1994 May 15; 212(1):151-4. PubMed ID: 7909754
    [Abstract] [Full Text] [Related]

  • 20. Parallel contractile signal transduction pathways activated by receptors for thrombin and epidermal growth factor-urogastrone in guinea pig gastric smooth muscle: blockade by inhibitors of mitogen-activated protein kinase-kinase and phosphatidyl inositol 3'-kinase.
    Zheng XL, Renaux B, Hollenberg MD.
    J Pharmacol Exp Ther; 1998 Apr 15; 285(1):325-34. PubMed ID: 9536028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.